149 related articles for article (PubMed ID: 36409102)
21. Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mallant-Hent RC; Lansdorp-Vogelaar I; Bossuyt PMM; Kuipers EJ; Dekker E; Spaander MCW
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):667-675.e1. PubMed ID: 31419575
[TBL] [Abstract][Full Text] [Related]
22. Systematic Review of Interventions to Increase Stool Blood Colorectal Cancer Screening in African Americans.
Roy S; Dickey S; Wang HL; Washington A; Polo R; Gwede CK; Luque JS
J Community Health; 2021 Feb; 46(1):232-244. PubMed ID: 32583358
[TBL] [Abstract][Full Text] [Related]
23. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.
Hawley ST; Volk RJ; Krishnamurthy P; Jibaja-Weiss M; Vernon SW; Kneuper S
Med Care; 2008 Sep; 46(9 Suppl 1):S10-6. PubMed ID: 18725820
[TBL] [Abstract][Full Text] [Related]
24. Optimal Strategies for Colorectal Cancer Screening.
Jain S; Maque J; Galoosian A; Osuna-Garcia A; May FP
Curr Treat Options Oncol; 2022 Apr; 23(4):474-493. PubMed ID: 35316477
[TBL] [Abstract][Full Text] [Related]
25. Perceptions of colorectal cancer screening in urban African American clinic patients: differences by gender and screening status.
Bass SB; Gordon TF; Ruzek SB; Wolak C; Ward S; Paranjape A; Lin K; Meyer B; Ruggieri DG
J Cancer Educ; 2011 Mar; 26(1):121-8. PubMed ID: 20443096
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in correlates of colorectal cancer screening among Black Medicare beneficiaries in Baltimore.
Martinez KA; Pollack CE; Phelan DF; Markakis D; Bone L; Shapiro G; Wenzel J; Howerton M; Johnson L; Garza MA; Ford JG
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1037-42. PubMed ID: 23629519
[TBL] [Abstract][Full Text] [Related]
27. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
28. Screening colonoscopy versus sigmoidoscopy: implications of a negative examination for cancer prevention and racial disparities in average-risk patients.
Wu BU; Longstreth GF; Ngor EW
Gastrointest Endosc; 2014 Nov; 80(5):852-61.e1-2. PubMed ID: 24814774
[TBL] [Abstract][Full Text] [Related]
29. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
31. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
Niedermaier T; Weigl K; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Jun; 32(6):481-493. PubMed ID: 28667446
[TBL] [Abstract][Full Text] [Related]
34. Spiritually based intervention to increase colorectal cancer screening among African Americans: screening and theory-based outcomes from a randomized trial.
Holt CL; Litaker MS; Scarinci IC; Debnam KJ; McDavid C; McNeal SF; Eloubeidi MA; Crowther M; Bolland J; Martin MY
Health Educ Behav; 2013 Aug; 40(4):458-68. PubMed ID: 23033548
[TBL] [Abstract][Full Text] [Related]
35. Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think.
Luque JS; Wallace K; Blankenship BF; Roos LG; Berger FG; LaPelle NR; Melvin CL
J Community Health; 2018 Dec; 43(6):1085-1092. PubMed ID: 29767821
[TBL] [Abstract][Full Text] [Related]
36. Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior?
James AS; Campbell MK; Hudson MA
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):529-34. PubMed ID: 12050093
[TBL] [Abstract][Full Text] [Related]
37. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
Oyalowo A; Forde KA; Lamanna A; Kochman ML
JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
[TBL] [Abstract][Full Text] [Related]
38. The Effectiveness of a Physician-Only and Physician-Patient Intervention on Colorectal Cancer Screening Discussions Between Providers and African American and Latino Patients.
Dolan NC; Ramirez-Zohfeld V; Rademaker AW; Ferreira MR; Galanter WL; Radosta J; Eder MM; Cameron KA
J Gen Intern Med; 2015 Dec; 30(12):1780-7. PubMed ID: 25986137
[TBL] [Abstract][Full Text] [Related]
39. Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA
Gastroenterology; 2020 Nov; 159(5):1695-1704.e1. PubMed ID: 32702368
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]